Please ensure Javascript is enabled for purposes of website accessibility

Bytes from AIPLA 8/7/2003August 13, 2003

The following are condensed articles featured in the AIPLA Report August 7, 2003. For complete articles, log on to Questioning Hatch/Waxman At an August 1 hearing before the Senate Judiciary Committee, representatives of the Justice Department and the PTO expressed reservations over certain provisions of legislation meant to reform procedures under the Hatch/Waxman Act by which generic drug makers obtain FDA approval to market their products. At the August 1 hearing, Deputy Assistant Attorney General Sheldon Bradshaw for the Justice Department

← Return to News & Events

Stay in Touch

Receive the latest news and updates from us and our attorneys.

Sign Up